| 摘要 |
A method of diagnosis of a brain damage-related disorder or the possibility thereof in a subject suspected of suffering therefrom, or of prognosis or therapeutic follow-up of a brain damage-related disorder in a subject, which comprises detecting Nucleoside diphosphate kinase A, or a variant or mutant thereof, and optionally at least one further polypeptide, or a variant or mutant thereof, selected from A-FABP, E-FABP, H-FABP, B-FABP, PGP 9.5, GFAP, Prostaglandin D synthase, Neuromodulin, Neurofilament L, Calcyphosine, RNA binding regulatory subunit, Ubiquitin fusion degradation protein 1 homolog, Glutathione S tranferase P, Cathepsin D, DJ-1 protein, Peroxiredoxin 5 and Peptidyl-prolyl cis-trans isomerase A (Cyclophilin A), in a sample of body fluid taken from the subject. |
